Literature DB >> 3471815

Brain microvascular smooth muscle expresses class II antigens.

M N Hart, M M Waldschmidt, J M Hanley-Hyde, S A Moore, J D Kemp, R L Schelper.   

Abstract

Mouse (BALB/c) splenic lymphocytes co-cultured in vitro with syngeneic brain-derived microvascular smooth muscle (SM) proliferate and become activated. After subsequent transfer of the activated lymphocytes to a syngeneic host, a vasculitis develops in the host. Investigation of the possible antigen-presenting properties of the cultured SM has resulted in the demonstration of class II (Ia) antigens on the SM. Fluorescence-activated cell sorter analysis has shown that an average of 31% of unstimulated SM cells in culture were positive when stained with an anti-IE of the appropriate haplotype (H2d), and an average of 20% were positive with an anti-IA of the H2d haplotype. Controls consisting of irrelevant antibodies of the same isotype, as well as an anti-IA of the H2s haplotype, were negative. In contrast, BALB/c-derived brain microvascular endothelial cells showed considerably less class II antigen expression (7% for both IA and IE).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3471815

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  3 in total

1.  Autoantibodies to vascular smooth muscle are pathogenic for vasculitis.

Authors:  Dana Carina Baiu; Brittany Barger; Matyas Sandor; Zsuzsa Fabry; Michael Noel Hart
Journal:  Am J Pathol       Date:  2005-06       Impact factor: 4.307

2.  Brain microvascular smooth muscle and endothelial cells produce granulocyte macrophage colony-stimulating factor and support colony formation of granulocyte-macrophage-like cells.

Authors:  M N Hart; Z Fabry; L Love-Homan; J Keiner; K L Sadewasser; S A Moore
Journal:  Am J Pathol       Date:  1992-08       Impact factor: 4.307

3.  Immune function of the blood-brain barrier: incomplete presentation of protein (auto-)antigens by rat brain microvascular endothelium in vitro.

Authors:  W Risau; B Engelhardt; H Wekerle
Journal:  J Cell Biol       Date:  1990-05       Impact factor: 10.539

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.